These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 20487562)

  • 21. MBNL1 and CUGBP1 modify expanded CUG-induced toxicity in a Drosophila model of myotonic dystrophy type 1.
    de Haro M; Al-Ramahi I; De Gouyon B; Ukani L; Rosa A; Faustino NA; Ashizawa T; Cooper TA; Botas J
    Hum Mol Genet; 2006 Jul; 15(13):2138-45. PubMed ID: 16723374
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Normal myogenesis and increased apoptosis in myotonic dystrophy type-1 muscle cells.
    Loro E; Rinaldi F; Malena A; Masiero E; Novelli G; Angelini C; Romeo V; Sandri M; Botta A; Vergani L
    Cell Death Differ; 2010 Aug; 17(8):1315-24. PubMed ID: 20431600
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Validation of plasma microRNAs as biomarkers for myotonic dystrophy type 1.
    Perfetti A; Greco S; Cardani R; Fossati B; Cuomo G; Valaperta R; Ambrogi F; Cortese A; Botta A; Mignarri A; Santoro M; Gaetano C; Costa E; Dotti MT; Silvestri G; Massa R; Meola G; Martelli F
    Sci Rep; 2016 Dec; 6():38174. PubMed ID: 27905532
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Alternative splicing of human insulin receptor gene (INSR) in type I and type II skeletal muscle fibers of patients with myotonic dystrophy type 1 and type 2.
    Santoro M; Masciullo M; Bonvissuto D; Bianchi ML; Michetti F; Silvestri G
    Mol Cell Biochem; 2013 Aug; 380(1-2):259-65. PubMed ID: 23666741
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Changes in myotonic dystrophy protein kinase levels and muscle development in congenital myotonic dystrophy.
    Furling D; Lam le T; Agbulut O; Butler-Browne GS; Morris GE
    Am J Pathol; 2003 Mar; 162(3):1001-9. PubMed ID: 12598332
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Analysis of Single Nucleotide Polymorphisms (SNPs) of the small-conductance calcium activated potassium channel (SK3) gene as genetic modifier of the cardiac phenotype in myotonic dystrophy type 1 patients.
    Rinaldi F; Botta A; Vallo L; Contino G; Morgante A; Iraci R; Catalli C; Silvestri G; Ventriglia VM; Politano L; Novelli G
    Acta Myol; 2008 Dec; 27(3):82-9. PubMed ID: 19472917
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Muscle pathology in myotonic dystrophy: light and electron microscopic investigation in eighteen patients.
    Nadaj-Pakleza A; Lusakowska A; Sułek-Piątkowska A; Krysa W; Rajkiewicz M; Kwieciński H; Kamińska A
    Folia Morphol (Warsz); 2011 May; 70(2):121-9. PubMed ID: 21630234
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Alternative splicing dysregulation secondary to skeletal muscle regeneration.
    Orengo JP; Ward AJ; Cooper TA
    Ann Neurol; 2011 Apr; 69(4):681-90. PubMed ID: 21400563
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Mef2 transcription network is disrupted in myotonic dystrophy heart tissue, dramatically altering miRNA and mRNA expression.
    Kalsotra A; Singh RK; Gurha P; Ward AJ; Creighton CJ; Cooper TA
    Cell Rep; 2014 Jan; 6(2):336-45. PubMed ID: 24412363
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Age of onset of RNA toxicity influences phenotypic severity: evidence from an inducible mouse model of myotonic dystrophy (DM1).
    Gladman JT; Mandal M; Srinivasan V; Mahadevan MS
    PLoS One; 2013; 8(9):e72907. PubMed ID: 24039817
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Overexpression of CUGBP1 in skeletal muscle from adult classic myotonic dystrophy type 1 but not from myotonic dystrophy type 2.
    Cardani R; Bugiardini E; Renna LV; Rossi G; Colombo G; Valaperta R; Novelli G; Botta A; Meola G
    PLoS One; 2013; 8(12):e83777. PubMed ID: 24376746
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dysregulation of Circular RNAs in Myotonic Dystrophy Type 1.
    Voellenkle C; Perfetti A; Carrara M; Fuschi P; Renna LV; Longo M; Sain SB; Cardani R; Valaperta R; Silvestri G; Legnini I; Bozzoni I; Furling D; Gaetano C; Falcone G; Meola G; Martelli F
    Int J Mol Sci; 2019 Apr; 20(8):. PubMed ID: 31010208
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identification of microRNAs in skeletal muscle associated with lung cancer cachexia.
    van de Worp WRPH; Schols AMWJ; Dingemans AC; Op den Kamp CMH; Degens JHRJ; Kelders MCJM; Coort S; Woodruff HC; Kratassiouk G; Harel-Bellan A; Theys J; van Helvoort A; Langen RCJ
    J Cachexia Sarcopenia Muscle; 2020 Apr; 11(2):452-463. PubMed ID: 31828982
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Temporal analysis of reciprocal miRNA-mRNA expression patterns predicts regulatory networks during differentiation in human skeletal muscle cells.
    Sjögren RJ; Egan B; Katayama M; Zierath JR; Krook A
    Physiol Genomics; 2015 Mar; 47(3):45-57. PubMed ID: 25547110
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Molecular, clinical, and muscle studies in myotonic dystrophy type 1 (DM1) associated with novel variant CCG expansions.
    Santoro M; Masciullo M; Pietrobono R; Conte G; Modoni A; Bianchi ML; Rizzo V; Pomponi MG; Tasca G; Neri G; Silvestri G
    J Neurol; 2013 May; 260(5):1245-57. PubMed ID: 23263591
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Transcriptome Analysis Reveals Altered Inflammatory Pathway in an Inducible Glial Cell Model of Myotonic Dystrophy Type 1.
    Azotla-Vilchis CN; Sanchez-Celis D; Agonizantes-Juárez LE; Suárez-Sánchez R; Hernández-Hernández JM; Peña J; Vázquez-Santillán K; Leyva-García N; Ortega A; Maldonado V; Rangel C; Magaña JJ; Cisneros B; Hernández-Hernández O
    Biomolecules; 2021 Jan; 11(2):. PubMed ID: 33530452
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Skeletal muscle features in myotonic dystrophy and sarcopenia: do similar nuclear mechanisms lead to skeletal muscle wasting?
    Malatesta M
    Eur J Histochem; 2012 Aug; 56(3):e36. PubMed ID: 23027352
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Six Serum miRNAs Fail to Validate as Myotonic Dystrophy Type 1 Biomarkers.
    Fernandez-Costa JM; Llamusi B; Bargiela A; Zulaica M; Alvarez-Abril MC; Perez-Alonso M; Lopez de Munain A; Lopez-Castel A; Artero R
    PLoS One; 2016; 11(2):e0150501. PubMed ID: 26919350
    [TBL] [Abstract][Full Text] [Related]  

  • 39. MicroRNA-206 is highly expressed in newly formed muscle fibers: implications regarding potential for muscle regeneration and maturation in muscular dystrophy.
    Yuasa K; Hagiwara Y; Ando M; Nakamura A; Takeda S; Hijikata T
    Cell Struct Funct; 2008; 33(2):163-9. PubMed ID: 18827405
    [TBL] [Abstract][Full Text] [Related]  

  • 40. TNF Signaling Acts Downstream of MiR-322/-503 in Regulating DM1 Myogenesis.
    Li M; Xu F; Liu Z; Wang C; Zhao Y; Zhu G; Shen X
    Front Endocrinol (Lausanne); 2022; 13():843202. PubMed ID: 35464065
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.